Protocol Ledger

NCT02956590 · Phase III · COMPLETED

Dyslipidemia of Obesity Intervention in Teens

Interventional Phase III clinical trial protocol NCT02956590 sponsored by Carelon Research in Cardiovascular and Thrombosis, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2018-05-01 Enrollment: 122 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT02956590
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)122 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT02956590
Protocol FieldVerified Registry Value
NCT IdentifierNCT02956590
Consolidated Lead SponsorCarelon Research
Therapeutic Condition CohortCardiovascular and Thrombosis
Clinical Trial PhasePhase III
Overall Recruitment StatusCOMPLETED
Registered Enrollment122 participants (ACTUAL)
Registered Start Date2018-05-01
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Cardiovascular and Thrombosis Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI